Evidence map›Paper›PMID 40402420›Full record

ArticleNeotropical entomology2025

Oxidative, Genotoxic and Epigenotoxic Effects of Pimpla turionellae Venom at Pharmacological Perspective.

Aslı Eskin, Zülbiye Demirtürk, Famil Yusufoğlu, Fevzi Uçkan

Abstract read
In one paragraph

Article in Neotropical entomology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aslı EskinDepartment of Biology, Kocaeli University, İzmit, Kocaeli, Türkiye.ORCID http://orcid.org/0000-0001-6272-5072
Zülbiye DemirtürkDepartment of Biology, Kocaeli University, İzmit, Kocaeli, Türkiye.ORCID http://orcid.org/0000-0002-3107-4278
Famil YusufoğluDepartment of Biology, Kocaeli University, İzmit, Kocaeli, Türkiye.ORCID http://orcid.org/0000-0002-4245-8074
Fevzi UçkanDepartment of Biology, Kocaeli University, İzmit, Kocaeli, Türkiye. fevzi.uckan@kocaeli.edu.tr.ORCID http://orcid.org/0000-0001-9304-4296

Funding

Kocaeli Üniversitesi FMP-2021-2656
6 · The paper itself

Abstract

Insects and mammals share a similar innate immune system. Galleria mellonella (L.), a beekeeping pest, is an alternative model organism for human health studies due to its immune response similarity and ability to be maintained at 37 °C. While oxidative stress and genotoxicity cause diseases, antioxidant enzymes and epigenetic mechanisms are effective in immunological response processes. Although parasitoid venoms are potential candidates for pharmacological applications such as anticoagulant, antibiotic, painkiller, antiviral and anticancer agents, the information pool is scarce to reflect their effects in humans. In an attempt to reveal the pharmaceutical significance of parasitoid venoms and their potential effects on human health, different venom doses of Pimpla turionellae (L.), the solitary endoparasitoid of G. mellonella, were injected into the host. Then, the levels of protein content, advanced oxidised protein products, lipid peroxidation, antioxidant power and glutathione in host haemolymph, and the amounts of methylation marker 5-methyldeoxycytidine monophosphate and strand breakage rates under neutral and alkaline conditions in host DNA were analysed. Principal component analysis was performed to determine the number of components that oxidative parameters depend on, and multivariate correlation analysis was applied to evaluate the effects of the parameters on each other. It was concluded that P. turionellae venom appeared to be one of the most effective pharmaceutical agents among parasitoid venoms. Also, the 0.01 venom reservoir equivalent dose qualified as immunotherapeutic dose.

Indexed as

DNA DamageEpigenesis, GeneticMothsOxidative StressWaspsWasp VenomsAnimalsWasp VenomsGalleria mellonellaParasitoid venomPharmaceuticsPimpla turionellae

Identifiers

PMID40402420
PMCPMC12098430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.